Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.3K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.7K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.7K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.6K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.6K
Atypical Pneumonia01:14

Atypical Pneumonia

73
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
73
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

962
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
962

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family.

The Biochemical journal·2007
Same author

[Investigation and analysis of China residents' environmental conservation desire].

Ying yong sheng tai xue bao = The journal of applied ecology·2007
Same author

[Analysis and identification of sea cucumber and products].

Guang pu xue yu guang pu fen xi = Guang pu·2007
Same author

Systematic identification of C. elegans miRISC proteins, miRNAs, and mRNA targets by their interactions with GW182 proteins AIN-1 and AIN-2.

Molecular cell·2007
Same author

HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination.

Proceedings of the National Academy of Sciences of the United States of America·2007
Same author

[Distribution and differentiation of marrow mesenchymal cells in tumor tissue: experimental with rabbits].

Zhonghua yi xue za zhi·2007

Related Experiment Video

Updated: Apr 21, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

632

[Primary pulmonary lymphoma: a case report].

Qingchun Zhao1, Sen Wei1, Xin Li1

  • 1Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin 300052, China.

Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|October 25, 2014
PubMed
Summary
This summary is machine-generated.

Primary pulmonary lymphoma (PPL) is a rare lung disorder involving abnormal lymph cell growth. This review discusses a rare PPL case, highlighting diagnostic and treatment challenges for this uncommon condition.

Related Experiment Videos

Last Updated: Apr 21, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

632

Area of Science:

  • Oncology
  • Pulmonology
  • Hematology

Background:

  • Primary pulmonary lymphoma (PPL) is a rare extranodal disorder characterized by clonal lymph cell proliferation within the lung.
  • PPL accounts for a small fraction (0.5%-1%) of primary lung tumors, often presenting with nonspecific clinical and imaging findings, leading to diagnostic challenges.

Observation:

  • This review details a rare case of primary pulmonary lymphoma.
  • The case highlights the difficulties in diagnosing PPL due to its nonspecific presentation.

Findings:

  • Diagnosis of PPL can be challenging due to nonspecific clinical and imaging features.
  • While treatment remains debated, common approaches include surgery and adjuvant chemotherapy.

Implications:

  • Improved awareness and diagnostic strategies are crucial for timely PPL identification.
  • Understanding rare PPL cases aids in refining treatment protocols and patient management.
  • Further research may clarify optimal therapeutic strategies for primary pulmonary lymphoma.